Careers  |  Sign In  |  Register  |   Twitter

Latest in Cardiology

Reuters reports that Isis Pharmaceuticals Inc. has developed a drug that has been shown to reduce levels of triglycerides in the blood by up to 64%. The drug, codenamed ISIS-APOCIIIRx, "works by inhibiting a cell's production of disease-causing protein." A recent trial tested the drug in 26 patients with...
An article in The New York Times reports that USPlabs has destroyed all inventory of their popular sports supplements, Jack3d and Oxyelite, under pressure from the F.D.A. The F.D.A ordered destruction of the products due to the presence of dimethylamylamine (DMAA), a chemical shown to elevate blood...
A study in Hypertension demonstrates that "prevalence rates of elevated blood pressure (BP) are increasing over time" in children. Researchers determined that the overall risk of elevated BP had risen 27% for children and teens between 1994 and 2008. The study focused on 11,638 children aged 8 to 17 whose...